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Data from medical 3D sensors, such as
computer tomography (CT) and mag-
netic resonance imaging (MRI), give 3D
information as output, thereby creating
the opportunity to model 3D objects
(e.g., organs, tissues, lesions) existing
inside the body. These quantitative
imaging techniques play a major role in
early diagnosis and make it possible to
continuously monitor the patient. With
the improvement of these sensors, a
large amount of 3D data with high spa-
tial resolution is acquired. Developing
efficient processing methods for this
diverse output is essential. 
Our “Content Based Analysis of
Medical Image Data” project, con-
ducted with Pázmány Péter Catholic
University, Faculty of Information
Technology and Bionics (PPKE ITK)
[L1], concentrated on the development
of image processing algorithms for mul-
timodal medical sensors (CT and MRI),
applying content-based information,
saliency models and fusing them with
learning-based techniques.  We devel-
oped fusion methods for efficient seg-
mentation of medical data, by inte-
grating the advantages of generative
segmentation models, applying tradi-
tional, “handcrafted” features; and the
currently preferred discriminative
models using convolutional features.
By fusing the two approaches, the draw-
backs of the different models can be
reduced, providing a robust perform-
ance on heterogeneous data, even with
previously unseen data acquired by dif-
ferent scanners. 
The fusion model [1] was introduced
and evaluated for brain tumour seg-
mentation on MRI volumes, using a
novel combination of multiple MRI
modalities and previously built healthy
templates as a first step to highlight
possible lesions. In the generative part
of the proposed model, a colour- and
spatial-based saliency model was
applied, integrating a priori knowledge
on tumours and 3D information
between neighbouring scan slices. The
saliency-based output is then com-
bined with convolutional neural net-
works to reduce the networks’ even-
tual overfitting which may result in
weaker predictions for unseen cases.
By introducing a proof-of-concept
method for the fusion of deep learning
techniques with saliency-based, hand-
crafted feature models, the fusion
approach has good abstraction skills,
yet can handle diverse cases for which
the net was less trained.
In a similar manner, we also imple-
mented a technique for liver segmenta-
tion in CT scans. First, a pre-processing
was introduced using a bone mask to
filter the abdominal region (this is
important in the case of whole-body
scans). Then a combination of region
growing, and active contour methods
was applied for liver region segmenta-
tion. This traditional feature-based
technique was fused with a convolu-
tional neural network’s prediction
mask to increase segmentation accu-
racy (Figure 1). 
The proposed techniques [2] have been
successfully applied in the “zMed”
project [L2], a four-year project run by
Zinemath Zrt., the Machine Perception
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Novel 3D sensors and augmented reality-based visualisation technology are being integrated for innovative
healthcare applications to improve the diagnostic process, strengthen the doctor-patient relationship and open new
horizons in medical education. Our aim is to help doctors and patients explain and visualise medical status using
computer vision and augmented reality. 
Figure1:Liversegmentationand3DmodellingonCTdata:Segmentationresultinaxial,
coronal,sagittalviewandtherendered3Dmodeloftheliver.
Figure2:ThemainmotivationsofthezMedproject[L2].
Research Laboratory in the Institute for
Computer Science and Control of the
Hungarian Academy of Sciences (MTA
SZTAKI) [L3] together with the
University of Pécs (PTE). The
Department of Radiology at PTE pro-
vides input data of different modalities
(CT and MRI) for the segmentation algo-
rithms, developed by the computer
vision researchers of MTA SZTAKI.
Based on these tools, Zinemath Zrt is
developing a software package, which
provides 3D imaging and visualisation
technologies for unified visualisation of
medical data and various sorts of spatial
measurements in an augmented reality
system. By creating a completely novel
visualisation mode and exceeding the
current display limits, the software
package applies novel technologies, such
as machine learning, augmented reality
and 3D image processing approaches.  
The developed software package is
planned to be adaptable to multiple
medical fields: medical education and
training for future physicians, intro-
ducing the latest methods more
actively; improving the doctor-patient
relationship by providing explanations
and visualisations of the illness; sur-
gical planning and preparation in the
pre-operative phase to reduce the plan-
ning time and contributing to a more
precisely designed procedure (Figure
2). 
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Identifying disease-causing genetic
characteristics starts with analysing
datasets containing the genetic informa-
tion of both healthy individuals and
patients with a disease of interest. The
data analysis provides direction to dis-
ease experts and lab researchers, who
can experimentally test whether a
genetic variant indeed causes disease.
Validated disease-causing genetic vari-
ants provide insight into the cellular
processes involved in disease, which is
the starting point for drug development.
Today’s predominant technique for
analysing genome datasets, called
genome-wide association studies
(GWAS), ensures that cause (genetic
variant) and effect (disease) can be
linked in a way the human mind can
grasp. GWAS examine each individual
genetic variants for correlation with dis-
ease, following well-understood statis-
tical principles. GWAS allows the
researcher to easily interpret findings
and has been very successful: many
potentially disease-causing variants
have been detected for various diseases.
However, several diseases stubbornly
resist such “human intelligence-based
approaches”, as their genetic architec-
ture is difficult to unravel. One architec-
tural feature that complicates analyses
considerably is epistasis[1]: genetic
variants do not necessarily just add up
their effects to establish effects, but
operate in terms of logical combina-
tions. Consider, for example, three vari-
ants A, B and C, which establish the dis-
ease-causing effects if (and only if) A is
not there, or B and C are both there.
Such complex logical relationships
reflect common biochemical gateways.
Analysing diseases with a more
involved genetic architecture, such as
cancer, type II diabetes or ALS, in terms
of “human mind perceivable”
approaches clearly has reached certain
limits. So, an immediate question is: if
the human mind is struggling, can AI
help out?
This motivated CWI researchers
Marleen Balvert and Alexander
Schönhuth to develop new, AI-based
techniques for identifying complex
combinations of genetic characteristics
that are associated with disease. The
challenge is twofold.
First, genome datasets contain millions
of genetic variants for thousands or tens
of thousands of individuals. Deep
neural networks - currently established
among the most successful classifica-
tion techniques [2] - offer enhanced
opportunities in processing large
datasets. This motivated Balvert and
Schönhuth to employ deep neural net-
works. 
Second, deep neural networks have
been predominantly developed for
Artificial Intelligence: understanding Diseases
that People Cannot understand?
by Marleen Balvert and Alexander Schönhuth (CWI)
Many diseases that we cannot currently cure, such as cancer, Alzheimer’s and amyotrophic lateral
sclerosis (ALS), are caused by variations in the DNA sequence. It is often unknown which characteristics
caused the disease. Knowing these would greatly help our understanding of the underlying disease
mechanisms, and would boost drug development. At CWI we develop methods based on artificial
intelligence (AI) to help find the genetic causes of disease, with promising first results.
